1. Providing pharmacy services during the coronavirus pandemic

   • Shao Liu
   • Ping Luo
   • Zhicheng Gong

   Commentary 28 March 2020 Pages: 299 - 304

   

2. Providing pharmacy services at cabin hospitals at the coronavirus epicenter in China

   • Long Meng
   • Feng Qiu
   • Shusen Sun

   Commentary 02 April 2020 Pages: 305 - 308

3. Combating drug shortages in China: surveillance warning and practice standardization

   • Yin Shi
   • Ping Yang
   • Boting Zhou

   Commentary 11 February 2020 Pages: 309 - 314

   

4. Pharmaceutical care services available in Danish community pharmacies

   • Bjarke Abrahamsen
   • Alaa Hassan Burghle
   • Charlotte Rossing

   Commentary 05 February 2020 Pages: 315 - 320

5. Ambulatory care pharmacy practice in China: status and future efforts

   • Lu Zhang
   • Yamin Huang
   • Jian Xiao

   Commentary 28 February 2020 Pages: 321 - 325

6. Ketogenic diet: a pharmaceutical guide for the management of drug therapy in the pediatric population

   • Yann-Eric Nisse
   • Sophie Robert
   • Béatrice Demore

   Commentary 17 March 2020 Pages: 326 - 330

   

7. Effect of health professional intervention on adherence to statin use according to the cause of patient non-adherence

   • Ainhoa Oñatibia-Astibia
   • Amaia Malet-Larrea
   • Estibaliz Goyenechea

   Short Research Report 16 April 2020 Pages: 331 - 335

   

8. Incidence of muscle relaxant use in relation to diagnosis of Parkinson’s disease

   • Anne Paakinaho
   • Niina Karttunen
   • Miia Tiihonen

   Short Research Report 06 March 2020 Pages: 336 - 340

   

9. Community pharmacy sales of non-prescribed antibiotics in Riyadh, Saudi Arabia: a simulated patient study

   • Mohamad Al-Tannir
   • Youssef Altannir
   • Isamme AlFayyad

   Short Research Report 16 April 2020 Pages: 341 - 346

10. Hypothalamic–pituitary–adrenal axis suppression by inhaled or nasal corticosteroids in HIV-infected patients

    • Femke Besemer
    • Cornelis Kramers
    • David M. Burger

    Short Research Report Open access 05 March 2020 Pages: 347 - 350

11. Oral levetiracetam for prevention of busulfan-induced seizures in adult hematopoietic cell transplant

    • Cristian Chaguaceda
    • Verónica Aguilera-Jiménez
    • Gisela Riu

    Short Research Report 06 February 2020 Pages: 351 - 354

12. Questionnaires on adherence to antihypertensive treatment: a systematic review of published questionnaires and their psychometric properties

    • Elisa Pareja-Martínez
    • Elisabeth Esquivel-Prados
    • José P. García-Corpas

    Review Article 05 February 2020 Pages: 355 - 365

    

13. The impact of the clinical pharmacist-led interventions in China: A systematic review and Meta-Analysis

    • Si-bei Qin
    • Xin-yi Zhang
    • Yi-min Cui

    Review Article 20 February 2020 Pages: 366 - 377

    

14. A scoping review of polypharmacy interventions in patients with stroke, heart disease and diabetes

    • Matthew V. Lum
    • Martin Y. S. Cheung
    • Brodie M. Sakakibara

    Review Article 21 April 2020 Pages: 378 - 392

    

15. Effects of generic exchange of solid oral dosage forms in neurological disorders: a systematic review

    • Johanna Weitzel
    • Susanne Erzkamp
    • Olaf Rose

    Review Article 09 April 2020 Pages: 393 - 417

    

16. Exploring pharmacy ethics in developing countries: a scoping review

    • Leen B. Fino
    • Iman A. Basheti
    • Betty B. Chaar

    Review Article 10 April 2020 Pages: 418 - 435

    

17. Orodispersible films as a personalized dosage form for nursing home residents, an exploratory study

    • J. Carolina Visser
    • Lisa Wibier
    • Katja Taxis

    Research Article Open access 13 February 2020 Pages: 436 - 444

    

18. Risk of major bleeding in elderly patients with atrial fibrillation on direct oral anticoagulants: real world experience

    • Petra Šinigoj
    • Nina Vene
    • Alenka Mavri

    Research Article 13 March 2020 Pages: 445 - 452

    

19. Prevalence of anticholinergic burden and risk factors amongst the older population: analysis of insurance claims data of Korean patients

    • Kwanghee Jun
    • Young-Mi Ah
    • Ju-Yeun Lee

    Research Article 13 April 2020 Pages: 453 - 461

    

20. Unfractionated heparin dosing in obese patients

    • Christopher George
    • Michael Barras
    • Karl Winckel

    Research Article 05 March 2020 Pages: 462 - 473

    

21. A clinical audit of oral anticoagulant therapy in aged care residents with atrial fibrillation

    • Nijole Bernaitis
    • Michelle Bowden
    • Adam La Caze

    Research Article 14 April 2020 Pages: 474 - 481

    

22. Trends of antihypertensive agents in patients with hypertension and coronary artery disease in a tertiary hospital of China

    • Yingming Zheng
    • Dandan Li
    • Su Shen

    Research Article 20 February 2020 Pages: 482 - 488

    

23. High-risk nonsteroidal anti-inflammatory drugs prescribing in primary care: results from National Medical Care Survey Malaysia

    • Wen Yea Hwong
    • Yvonne Mei Fong Lim
    • Sheamini Sivasampu

    Research Article 20 January 2020 Pages: 489 - 499

    

24. Comparison of drug survival between infliximab and adalimumab in inflammatory bowel disease

    • Mayte Gil-Candel
    • Juan José Gascón-Cánovas
    • Carles Iniesta-Navalón

    Research Article 31 January 2020 Pages: 500 - 507

    

25. Medication exposure and frailty in older community-dwelling patients: a cross-sectional study

    • Elsa Reallon
    • Bénédicte Chavent
    • Teddy Novais

    Research Article 05 March 2020 Pages: 508 - 514

26. Impact of HIV and chronic kidney disease comorbidities on hepatitis C treatment choices, drug–drug interactions and hepatitis C cure

    • Salamat Ali
    • Tofeeq Ur-Rehman
    • Vibhu Paudyal

    Research Article Open access 25 February 2020 Pages: 515 - 526

    

27. Appropriateness of empirical antibiotics: risk factors of adult patients with sepsis in the ICU

    • Khalid Ahmad Al-Sunaidar
    • Noorizan Prof. Abd Aziz
    • Yahaya Prof. Hassan

    Research Article 06 March 2020 Pages: 527 - 538

    

28. Survey of healthcare professionals’ practices, expectations, and attitudes towards provision of patient information leaflets in Thailand

    • Narumol Jarernsiripornkul
    • Sireerat Nakboon
    • Kamonphat Wongtaweepkij

    Research Article 18 January 2020 Pages: 539 - 548

29. Doctors’ perceptions, expectations and experience regarding the role of pharmacist in hospital settings of Pakistan

    • Nabeel Khan
    • Ken McGarry
    • Keith Holden

    Research Article 17 February 2020 Pages: 549 - 566

30. Home medicines reviews and residential medication management reviews in Western Australia

    • Petra Czarniak
    • Laetitia Hattingh
    • Bruce Sunderland

    Research Article 12 March 2020 Pages: 567 - 578

    

31. Prescription of potentially inappropriate medications in elderly outpatients: a survey using 2015 Japanese Guidelines

    • Keiko Fujie
    • Risa Kamei
    • Koichi Hashimoto

    Research Article Open access 21 January 2020 Pages: 579 - 587

    

32. Prevalence and risk factors of drug-related problems identified in pharmacy-based medication reviews

    • Raphael Sell
    • Marion Schaefer

    Research Article Open access 05 February 2020 Pages: 588 - 597

    

33. Potentially inappropriate medications in Chinese community-dwelling older adults

    • Yamin Huang
    • Lu Zhang
    • Jian Xiao

    Research Article 05 February 2020 Pages: 598 - 603

34. Prescribing errors in pediatric outpatient department at a tertiary care hospital in Malaysia

    • Jian Lynn Lee

    Research Article 25 February 2020 Pages: 604 - 609

35. Quality assessment and cost saving of renal dosing recommendation by clinical pharmacists at medical wards in Thailand

    • Sayamon Sukkha
    • Wipharak Rattanavipanon
    • Junporn Kongwatcharapong

    Research Article 27 March 2020 Pages: 610 - 616

    

36. The effect of inpatient pharmaceutical care on nephrotic syndrome patients after discharge: a randomized controlled trial

    • Donghong Yin
    • Qian Guo
    • Jinju Duan

    Research Article 13 March 2020 Pages: 617 - 624

    

37. Effectiveness of pharmacist intervention model for chronic kidney disease patients; a prospective comparative study

    • Aisha Khokhar
    • Yusra Habib Khan
    • Nida Bokharee

    Research Article 05 February 2020 Pages: 625 - 634

    

38. Correlation between haemoglobin level and type of erythropoiesis-stimulating agent at initiation of haemodialysis

    • Masaki Higashiura
    • Masaki Ohya
    • Takashi Shigematsu

    Research Article 06 February 2020 Pages: 635 - 641

    

39. Impact of chemotherapy schedule modification on breast cancer patients: a single-centre retrospective study

    • Gobi Hariyanayagam Gunasekaran
    • Mohamed Azmi Bin Ahmad Hassali
    • Muhammad Tahar Bin Rahman

    Research Article 17 March 2020 Pages: 642 - 651

    

40. Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients

    • Rashida Muhammad Umar
    • Sule Apikoglu-Rabus
    • Perran Fulden Yumuk

    Research Article 20 February 2020 Pages: 652 - 661

41. A modified olanzapine-based anti-emetic regimen for the control of nausea and vomiting in patients receiving weekly cisplatin

    • Nikita Mehra
    • Vasanth Christopher
    • Prasanth Ganesan

    Research Article 09 March 2020 Pages: 662 - 666

    

42. Translation and psychometric validation of a Danish version of the medication-related quality of life scale

    • Laura Victoria Jedig Lech
    • Elín Dröfn Jónsdóttir
    • Anna Birna Almarsdóttir

    Research Article 05 February 2020 Pages: 667 - 676

    

43. Gap between patient expectation and perception during pharmacist–patient communication at community pharmacy

    • Myeong Gyu Kim
    • Na Eun Lee
    • Hyun Soon Sohn

    Research Article 07 April 2020 Pages: 677 - 684

44. Evaluation of a program of pharmaceutical counseling for French patients on oral anticoagulant therapy

    • C. Roseau
    • C. Richard
    • M.-C. Chaumais

    Research Article 13 January 2020 Pages: 685 - 694

    

45. Development and psychometric evaluation of the patient’s HIV knowledge questionnaire (PHKQ)

    • Idongesit L. Jackson
    • Jegbefume M. Okonta
    • Chinwe V. Ukwe

    Research Article 14 January 2020 Pages: 695 - 702

46. Population pharmacokinetics of busulfan in Saudi pediatric patients undergoing hematopoietic stem cell transplantation

    • Abdullah Alsultan
    • Ahmed A. Albassam
    • Salman Alfadhel

    Research Article 05 March 2020 Pages: 703 - 712

    

47. Bullous pemphigoid associated with the use of dipeptidil peptidase-4 inhibitors: analysis from studies based on pharmacovigilance databases

    • Juan A. Molina-Guarneros
    • María Sainz-Gil
    • Luis H. Martin

    Research Article Open access 05 March 2020 Pages: 713 - 720

    

48. Aromatase inhibitors associated osteonecrosis of jaw: signal refining to identify pseudo safety signals

    • Reddy Neha
    • Elsa Beulah
    • Viswam Subeesh

    Research Article 08 April 2020 Pages: 721 - 727

    

49. The quality assessment of the Japanese Adverse Drug Event Report database using vigiGrade

    • Masami Tsuchiya
    • Taku Obara
    • Nariyasu Mano

    Research Article 04 February 2020 Pages: 728 - 736

    

50. Pharmacy and therapeutics committees strategy to address olmesartan safety issues at a primary care level

    • Marina Rovira-Illamola
    • Neus Pagès-Puigdemont
    • Mercè Casasayas-Guilera

    Research Article 20 February 2020 Pages: 737 - 743